levicure.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.levicure.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change | ||
Meta Tags
| Title | Home | |
| Description | ABOUT Levicure Ltd. is an Israeli start-up that aims to provide an effective oral treatment for type 1 diabetes mellitus (T1DM) with patented IP consisting of a combination of three FDA approved |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | |
| Location |
Related Websites
| Site | Rank |
More to Explore
levicure.com Valuation
|
US$1,592
Last updated: 2023-05-17 08:59:09
levicure.com has Semrush global rank of 0. levicure.com has an estimated worth of US$ 1,592, based on its estimated Ads revenue. levicure.com receives approximately 183 unique visitors each day. Its web server is located in , with IP address . According to SiteAdvisor, levicure.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,592 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$44 |
| Yearly Ads Revenue | US$529 |
| Daily Unique Visitors | 12 |
| Note: All traffic and earnings values are estimates. | |
HtmlToTextCheckTime:2023-05-17 08:59:09
| top of page Home About ABOUT US Levicure is a start-up in Israel focused on providing patients with type 1 diabetes (T1D) a safe and scalable oral medication that can lower insulin requirements and induce remission. Our patented combination therapy consists of two FDA approved drugs and GABA. A clinical proof-of-concept study in T1D patients and animal models demonstrated that the treatment could facilitate remission of T1D by restoring the body’s own insulin production, in some cases leading to complete insulin withdrawal in humans. This scalable treatment can provide T1D patients with a safe, non-invasive, orally administered medication that facilitates remission, reduces complications, and vastly improves quality of life. CHALLENGE T1D is an incurable, life-threatening disease, where the insulin producing pancreatic β-cells are destroyed by the patient’s immune system. To survive T1D patients must take daily insulin injections and continuously monitor their blood glucose for the |
levicure.com Whois Information
Domain Name: LEVICURE.COM Registry Domain ID: 2667935777_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.reg.com Registrar URL: http://www.reg.ru Updated Date: 2022-01-28T21:18:58Z Creation Date: 2022-01-13T09:15:18Z Registry Expiry Date: 2024-01-13T09:15:18Z Registrar: REGISTRAR OF DOMAIN NAMES REG.RU LLC Registrar IANA ID: 1606 Domain Status: clientHold https://icann.org/epp#clientHold Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.HOSTING.REG.RU Name Server: NS2.HOSTING.REG.RU DNSSEC: unsigned >>> Last update of whois database: 2022-03-16T09:18:03Z <<< |